98574-91-5

Upstream product

• 108-24-7 acetic anhydride 
• 85716-51-4 Acetic acid (1R,2R,3S,4R,5R)-4-acetoxy-2-[(2R,3R,4S,5R,6R)-3,4-diacetoxy-6-methyl-5-((1R,4S,5R,6R)-4,5,6-triacetoxy-3-acetoxymethyl-cyclohex-2-enylamino)-tetrahydro-pyran-2-yloxy]-6,8-dioxa-bicyclo[3.2.1]oct-3-yl ester 
• 85716-51-4 2,3,2',3'-tetra-O-acetyl-1,6-anhydro-4',6'-dideoxy-4'-<(1R)-(1,5/4,6)-4,5,6-triacetoxy-3-acetoxymethyl-2-cyclohexenylamino>-β-cellobiose 
• 85716-51-4 N-<(1S)-(1,4,6/5)-4,5,6-triacetoxy-3-acetoxymethyl-2-cyclohexenyl>-2,3,2',3'-tetra-O-acetyl-4'-amino-1,6-anhydro-4',6'-dideoxy-β-maltose 

Relevant academic research and scientific papers

SYNTHESIS OF AMYLOSTATIN (XG), α-GLUCOSIDASE INHIBITOR WITH BASIC PSEUDOTRISACCHARIDE STRUCTURE

The basic pseudotrisaccharide (1) constituting the common and essential building block of several α-glucosidase inhibitors of microbial origin was synthesized by coupling two synthons: the chiral cyclohexyl halide (11) and the 4'-amino-4'-deoxy-disaccharide (14).